FEB 17, 2017 10:56 AM PST

Immunotherapy Strategy Could Stop the Progression of Diabetes Type 1

WRITTEN BY: Xuan Pham

For patients with diabetes Type 1, an experimental therapy may be able to slow the progression of their disease. By training the body’s immune cells to stop their attack on insulin producing cells, researchers in Sweden say there’s a new way around diabetes Type 1.

Diabetes mellitus is one of the most common chronic disorders that is characterized by the body’s inability to regulate blood glucose levels. In type 1 diabetes, insulin is not made in enough quantities because the insulin producing cells (beta cells) are attacked and destroyed by the body’s own immune system. As a result, the body is unable to regulate blood sugar levels normally, and diabetics must take great care in monitoring their activity, diet, and glucose levels. This involves daily blood checks and even insulin injections.

But scientists in Sweden see a ripe opportunity for therapy in that not all beta cells die off at once. If they can slow down the destruction of the beta cells, the effects of diabetes may not be so severe.

Indeed, the team, led by Dr. Johnny Ludvigsson, found a way to tame the immune system and make it less aggressive towards the beta cells. To do so, they injected the lymph nodes of six patients with a protein called GAD, which is normally found on the beta cells. Exposure to these proteins, they reasoned, should make the beta cells appear less foreign to the immune cells, and thereby reduce the odds of systemic attack.

Between six and 15 months after the treatment, Ludvigsson’s team followed up with the patients. They report that all six patients showed no marked decline in their diabetes condition. In fact, they seemed to be at a steady state, relative to their disease status upon diagnosis of the diabetes.

"This method has shown the best efficacy so far," said Ludvigsson, senior professor of pediatrics at Linköping University. "But we have to be cautious. The number of patients is small."

It seems injecting GAD directly to the lymph node made all the difference, as previous attempts at introducing GAD through the skin were not nearly as effective. "With a much lower dose, we got a very strong desired effect on the immune system," Ludvigsson said.

The team plans to test their newfound small trial success in larger trials next.

Additional sources: Live Science

About the Author
  • I am a human geneticist, passionate about telling stories to make science more engaging and approachable. Find more of my writing at the Hopkins BioMedical Odyssey blog and at TheGeneTwist.com.
You May Also Like
AUG 10, 2020
Cancer
A New Prognostic Biomarker for Paclitaxel Sensitivity in Breast Cancer
AUG 10, 2020
A New Prognostic Biomarker for Paclitaxel Sensitivity in Breast Cancer
Breast cancer is one of the deadliest cancers globally. It has been studied extensively with plenty of treatments availa ...
SEP 14, 2020
Health & Medicine
Direct Amplification: Rapid, Extraction-Free RT-qPCR Results
SEP 14, 2020
Direct Amplification: Rapid, Extraction-Free RT-qPCR Results
As the SARS-CoV-2 pandemic continues to rage across the United States and around the globe, the demand for COVID-19 test ...
OCT 06, 2020
Clinical & Molecular DX
A Smart Tattoo That Could Save Your Life
OCT 06, 2020
A Smart Tattoo That Could Save Your Life
Color-changing tattoos, powered by nanotechnology, that sense imbalances in your biochemistry providing a visual signal ...
OCT 14, 2020
Cancer
Using Plasma Scalpels with Chemotherapy Against Brain Cancer
OCT 14, 2020
Using Plasma Scalpels with Chemotherapy Against Brain Cancer
Cold atmospheric plasma is a relatively new technique that utilizes a tool that generates a sort of plasma scalpel, exce ...
NOV 09, 2020
Cancer
A Prognostic Expression Profile for Osteosarcoma
NOV 09, 2020
A Prognostic Expression Profile for Osteosarcoma
Tireless research goes into every cancer diagnostic tools and new therapy. Many types of cancer have made giant steps fo ...
NOV 09, 2020
Genetics & Genomics
Potential Problems with Liquid Biopsies
NOV 09, 2020
Potential Problems with Liquid Biopsies
Liquid biopsies are tests that look for biomarkers in the blood, which can help inform the treatment of cancer. The tool ...
Loading Comments...